Penn State Hershey Cancer Institute Research
Welcome to Penn State Hershey Cancer Institute
Intellect and discovery characterize growth at the Penn State Hershey Cancer Institute. We continue to emphasize our state-of-the-art interdisciplinary patient care, in which medical, surgical and radiation oncologists jointly determine the best therapeutic course for each patient. We also focus our attention on becoming designated by the National Cancer Institute (NCI). Among other strengths, the Cancer Institute's emphasis on rural, underserved populations is a focus of the CCSG application. Many of these efforts are conducted through the Appalachian Cancer Network by volunteers throughout Pennsylvania who provide education and screening services, as well as behavioral interventions, to reduce cancer risk. Our free-standing facility, which opened June 2009, was designed to reinforce our concept of a community of individuals devoted to providing comprehensive cancer care and finding a cure for cancer.
The Cancer Institute's four scientific programs:
- Cancer Virology and Immunology
- Mechanisms of Carcinogenesis and Chemoprevention
- Cancer Control and Population Health
- Experimental Therapeutics
The scientists in the Cancer Control and Population Health and the Mechanisms of Carcinogenesis and Chemoprevention Programs continue collaborative work on two major grants examining the role of tobacco in leading to cancer. In the Experimental Therapeutics Program, our scientists have been awarded several grants from NCI in the area of nanotechnology. These projects, developed with leading researchers at University Park, are aimed at delivering new cancer treatments to individual cancer cells. Through our network of local hospitals throughout central and northeastern Pennsylvania, the Penn State Hershey Cancer Institute brings research to patients in a growing number of communities. Click here for a list of our partners and affiliates.
We continue to expand our research programs. PSHCI now has 143 investigators from 25 academic departments in six colleges located at the Hershey and University Park campuses. Over the past five years, our NCI funding has increased by 16% with a 22% increase in the past 3 years. This is quite impressive given the funding crisis at the NIH. We are making similar strides in the area of clinical trials. In the past year, 18% of our new cancer patients were enrolled on a therapeutic or prevention trial.
Penn State Hershey undergoing final phase of radiology expansion
Ongoing renovations to the radiology area on the ground floor of the hospital at Penn State Milton S. Hershey Medical Center will make room for additional equipment and give admitted patients awaiting diagnostic procedures a more accessible, private space.More...
Innovation key to Penn State Hershey’s future, says medical center's CEO
Penn State's medical school, university hospital and health system continue to be a magnet for future health professionals, a preferred medical destination for patients across Pennsylvania, and a pioneer in personalized medicine research according to Harold L. Paz, Penn State Hershey Medical Center and Health System CEO and Penn State’s senior vice president for health affairs and dean of Penn State College of Medicine.More...
The Medical Minute: Some thoughts about organics and 'superfoods'
Winter has worn out its welcome. People are eagerly looking forward to the warm weather, getting outside, and indulging once again in fresh, local produce. As consumers inundated with choices, we often wonder what’s the best food to purchase — to go organic or not.More...
Penn State Hershey IBD experts to host event at Penn State York
In an effort to help patients in the York County area living with inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis, experts with Penn State Hershey Inflammatory Bowel Disease Center will host a patient symposium on from 6 to 9 p.m. Tuesday, March 18, in the rehearsal room of the Pullo Performing Arts Center on the Penn State York campus.More...